Aruba Shareholder Alert – Investors encouraged to contact law firm

Aruba Shareholder Alert — National Securities Law Firm Seeks Higher Price For Shareholders In Connection With Acquisition, And Encourages Shareholders To Contact Law Firm For More Information

March 2, 2015
New York, New York

Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the acquisition of Aruba Networks (NASDAQ: ARUN) (“Aruba” or the “Company”) on behalf of its shareholders. Aruba announced that it has entered into a definitive merger agreement with Hewlett-Packard (“HP”) for HP to acquire all of the outstanding shares of Aruba common stock for $24.67 per share in cash.

Our investigation has determined that the offer price of only $24.67 per share unfairly under-values the true going forward inherent value of the Company and that shareholders are not receiving the maximum value for their shares. Indeed, among other things, analyst have projected that the Company’s stock is worth at least $34 per share, and the stock traded as high as $24.81 recently. The investigation further seeks to determine whether senior management of Aruba are acting in their own self-interests at the expense of shareholders in selling the Company.

If you are a shareholder of Aruba and would like additional information as to how the acquisition may affect your rights as a shareholder, and how you may be eligible to obtain a higher price for your shares, at no cost or expense, please contact us toll free at 1-800-906-6432 or contact us via our website.

Tripp Levy PLLC represents individual and institutional shareholders in mergers and acquisitions transactions and, along with its affiliate, has recovered billions of dollars for shareholders in securities actions around the globe. Tripp Levy PLLC is affiliated with the law firm Milberg LLP. The National Law Journal has named Milberg one of the “50 Elite Trial Lawyer Firms” and one of the “50 Leading Plaintiff Firms in America.” Attorney advertising. Prior results do not indicate a similar outcome.